These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37326323)

  • 1. Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    Blankestijn PJ; Vernooij RWM; Hockham C; Strippoli GFM; Canaud B; Hegbrant J; Barth C; Covic A; Cromm K; Cucui A; Davenport A; Rose M; Török M; Woodward M; Bots ML;
    N Engl J Med; 2023 Aug; 389(8):700-709. PubMed ID: 37326323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes.
    Grooteman MP; van den Dorpel MA; Bots ML; Penne EL; van der Weerd NC; Mazairac AH; den Hoedt CH; van der Tweel I; Lévesque R; Nubé MJ; ter Wee PM; Blankestijn PJ;
    J Am Soc Nephrol; 2012 Jun; 23(6):1087-96. PubMed ID: 22539829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled Trial.
    Kang A; Arnold R; Gallagher M; Snelling P; Green J; Fernando M; Kiernan MC; Hand S; Grimley K; Burman J; Heath A; Rogers K; Bhattacharya A; Smyth B; Bradbury T; Hawley C; Perkovic V; Krishnan AV; Jardine MJ;
    Clin J Am Soc Nephrol; 2021 Sep; 16(9):1365-1375. PubMed ID: 34233923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis.
    Zhu Y; Li J; Lu H; Shi Z; Wang X
    BMC Nephrol; 2024 Oct; 25(1):372. PubMed ID: 39438899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials.
    Bignardi PR; Delfino VDA
    Hemodial Int; 2024 Apr; 28(2):139-147. PubMed ID: 38369730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration.
    Rose M; Fischer FH; Liegl G; Strippoli GFM; Hockham C; Vernooij RWM; Barth C; Canaud B; Covic A; Cromm K; Cucui AM; Davenport A; Fischer KI; Hegbrant J; Jaha H; Schappert A; Török M; Woodward M; Bots ML; Blankestijn PJ;
    Kidney Int; 2024 Nov; 106(5):961-971. PubMed ID: 39089577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARAMETERS OF HEMODIALYSIS ADEQUACY AND PATIENTS' SURVIVAL DEPENDING ON TREATMENT MODALITIES.
    Đurić PS; Popović J; Janković A; Tošić J; Dimković N
    Med Pregl; 2015; 68(7-8):251-7. PubMed ID: 26591638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why choose high volume online post-dilution hemodiafiltration?
    Basile C; Davenport A; Blankestijn PJ
    J Nephrol; 2017 Apr; 30(2):181-186. PubMed ID: 27586123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.
    Morena M; Jaussent A; Chalabi L; Leray-Moragues H; Chenine L; Debure A; Thibaudin D; Azzouz L; Patrier L; Maurice F; Nicoud P; Durand C; Seigneuric B; Dupuy AM; Picot MC; Cristol JP; Canaud B;
    Kidney Int; 2017 Jun; 91(6):1495-1509. PubMed ID: 28318624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.
    Maduell F; Moreso F; Pons M; Ramos R; Mora-Macià J; Carreras J; Soler J; Torres F; Campistol JM; Martinez-Castelao A;
    J Am Soc Nephrol; 2013 Feb; 24(3):487-97. PubMed ID: 23411788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hemodiafiltration superior to hemodialysis in patients with kidney failure?
    Drüeke TB; Ikizler TA
    Kidney Int; 2023 Nov; 104(5):874-877. PubMed ID: 37863633
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Maduell F; Varas J; Ramos R; Martin-Malo A; Pérez-Garcia R; Berdud I; Moreso F; Canaud B; Stuard S; Gauly A; Aljama P; Merello JI
    Am J Nephrol; 2017; 46(4):288-297. PubMed ID: 29041011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Am J Kidney Dis; 2014 Jun; 63(6):954-67. PubMed ID: 24434188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis modality and quality of life: more answers yet more questions.
    Hamdan H; Roshanravan B
    Kidney Int; 2024 Nov; 106(5):792-794. PubMed ID: 39428172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-flux hemodialysis and hemodiafiltration on the mortality of patients with end-stage kidney disease: a meta-analysis.
    Ma S; Pu N; Ma J
    Ren Fail; 2023 Dec; 45(1):2147436. PubMed ID: 37427760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity of renal support in critically ill patients with acute kidney injury.
    ; Palevsky PM; Zhang JH; O'Connor TZ; Chertow GM; Crowley ST; Choudhury D; Finkel K; Kellum JA; Paganini E; Schein RM; Smith MW; Swanson KM; Thompson BT; Vijayan A; Watnick S; Star RA; Peduzzi P
    N Engl J Med; 2008 Jul; 359(1):7-20. PubMed ID: 18492867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversy on the CONVINCE study findings: the PRO take.
    Canaud B; Blankestijn P
    J Bras Nefrol; 2024; 46(2):e2024PO01. PubMed ID: 38358914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.